Search

everythinglearnresearchcommunity

for

Search:↓

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

New treatments aim to improve thin endometrium to help more couples with infertility.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Plant compounds may offer a promising alternative for cancer treatment.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Finasteride reduces hair growth and is safe for women with excessive hair.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.